Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Tipo de estudo
Intervalo de ano de publicação
1.
World J Gastroenterol ; 16(4): 403-10, 2010 Jan 28.
Artigo em Inglês | MEDLINE | ID: mdl-20101763

RESUMO

Probiotic bacteria have well-established beneficial effects in the management of diarrhoeal diseases. Newer evidence suggests that probiotics have the potential to reduce the risk of developing inflammatory bowel diseases and intestinal bacterial overgrowth after gut surgery. In liver health, the main benefits of probiotics might occur through preventing the production and/or uptake of lipopolysaccharides in the gut, and therefore reducing levels of low-grade inflammation. Specific immune stimulation by probiotics through processes involving dendritic cells might also be beneficial to the host immunological status and help prevent pathogen translocation. Hepatic fat metabolism also seems to be influenced by the presence of commensal bacteria, and potentially by probiotics; although the mechanisms by which probiotic might act on the liver are still unclear. However, this might be of major importance in the future because low-grade inflammation, hepatic fat infiltration, and hepatitis might become more prevalent as a result of high fat intake and the increased prevalence of obesity.


Assuntos
Gastroenteropatias/tratamento farmacológico , Hepatopatias/tratamento farmacológico , Probióticos/uso terapêutico , Humanos , Mucosa Intestinal/efeitos dos fármacos , Fígado/efeitos dos fármacos , Probióticos/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA